Gene Symbol | Gene ID | Gene Info |
---|---|---|
HDX
|
ENSG00000165259.9 | highly divergent homeobox |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_83757144_83757379 | HDX | 138 | 0.592747 | 0.49 | 1.8e-01 | Click! |
chrX_83757689_83757840 | HDX | 277 | 0.521815 | -0.45 | 2.2e-01 | Click! |
chrX_83757427_83757578 | HDX | 15 | 0.512642 | -0.22 | 5.7e-01 | Click! |
chrX_83756437_83756588 | HDX | 887 | 0.451157 | 0.11 | 7.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr21_34085576_34085727 | 1.43 |
SYNJ1 |
synaptojanin 1 |
13555 |
0.15 |
chr21_34085958_34086109 | 1.17 |
SYNJ1 |
synaptojanin 1 |
13173 |
0.15 |
chr11_36433312_36433542 | 1.00 |
PRR5L |
proline rich 5 like |
10812 |
0.18 |
chr1_198658673_198658824 | 1.00 |
RP11-553K8.5 |
|
22558 |
0.23 |
chr20_1602237_1602443 | 0.91 |
RP4-576H24.4 |
Uncharacterized protein |
1685 |
0.24 |
chr2_162852542_162852808 | 0.88 |
AC008063.2 |
|
77091 |
0.09 |
chr16_11059004_11059432 | 0.88 |
CLEC16A |
C-type lectin domain family 16, member A |
20780 |
0.13 |
chrX_70318458_70318852 | 0.87 |
FOXO4 |
forkhead box O4 |
2276 |
0.17 |
chr3_13050762_13050913 | 0.87 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
22301 |
0.24 |
chr5_67550264_67550491 | 0.87 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
14651 |
0.26 |
chr13_42968234_42968447 | 0.84 |
AKAP11 |
A kinase (PRKA) anchor protein 11 |
122051 |
0.06 |
chr11_47949983_47950362 | 0.79 |
PTPRJ |
protein tyrosine phosphatase, receptor type, J |
51941 |
0.12 |
chr5_49932475_49932649 | 0.78 |
PARP8 |
poly (ADP-ribose) polymerase family, member 8 |
29171 |
0.26 |
chr4_154730657_154731010 | 0.75 |
SFRP2 |
secreted frizzled-related protein 2 |
20561 |
0.19 |
chr2_182178443_182178616 | 0.75 |
ENSG00000266705 |
. |
8150 |
0.32 |
chr2_169033675_169033826 | 0.73 |
STK39 |
serine threonine kinase 39 |
70901 |
0.13 |
chr4_149344107_149344258 | 0.73 |
NR3C2 |
nuclear receptor subfamily 3, group C, member 2 |
13830 |
0.3 |
chr13_41547224_41547475 | 0.73 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
9069 |
0.2 |
chr5_142789348_142789499 | 0.72 |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
4535 |
0.34 |
chr3_43079553_43079704 | 0.72 |
FAM198A |
family with sequence similarity 198, member A |
58588 |
0.1 |
chr7_114660359_114660758 | 0.71 |
MDFIC |
MyoD family inhibitor domain containing |
86634 |
0.1 |
chr11_128162482_128162771 | 0.70 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
212663 |
0.02 |
chr10_11185263_11185615 | 0.70 |
CELF2 |
CUGBP, Elav-like family member 2 |
21554 |
0.19 |
chr15_63783171_63783387 | 0.70 |
USP3 |
ubiquitin specific peptidase 3 |
13514 |
0.23 |
chr8_125575470_125576116 | 0.69 |
MTSS1 |
metastasis suppressor 1 |
2175 |
0.26 |
chr17_15495175_15495615 | 0.69 |
CDRT1 |
CMT1A duplicated region transcript 1 |
1327 |
0.34 |
chr1_111689880_111690031 | 0.68 |
CEPT1 |
choline/ethanolamine phosphotransferase 1 |
7107 |
0.14 |
chr17_33585969_33586120 | 0.67 |
SLFN5 |
schlafen family member 5 |
15936 |
0.14 |
chrX_40030001_40030215 | 0.66 |
BCOR |
BCL6 corepressor |
6465 |
0.32 |
chr3_136639103_136639532 | 0.66 |
NCK1 |
NCK adaptor protein 1 |
7564 |
0.2 |
chr7_150443855_150444311 | 0.65 |
GIMAP5 |
GTPase, IMAP family member 5 |
9647 |
0.16 |
chr7_50320921_50321337 | 0.65 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
23195 |
0.25 |
chr7_3048587_3048738 | 0.64 |
ENSG00000201794 |
. |
9934 |
0.23 |
chr19_19710111_19710297 | 0.64 |
AC002306.1 |
|
6955 |
0.12 |
chr7_129545877_129546028 | 0.64 |
UBE2H |
ubiquitin-conjugating enzyme E2H |
45215 |
0.1 |
chr14_20442882_20443033 | 0.64 |
OR4K15 |
olfactory receptor, family 4, subfamily K, member 15 |
646 |
0.64 |
chr1_207307763_207307914 | 0.64 |
C4BPA |
complement component 4 binding protein, alpha |
30187 |
0.15 |
chr14_75900699_75900850 | 0.63 |
JDP2 |
Jun dimerization protein 2 |
1937 |
0.33 |
chr4_36269076_36269227 | 0.63 |
RP11-431M7.3 |
|
11011 |
0.2 |
chr1_111731976_111732240 | 0.63 |
RP5-1180E21.5 |
|
4425 |
0.14 |
chr20_57695964_57696140 | 0.62 |
ZNF831 |
zinc finger protein 831 |
70023 |
0.09 |
chr9_116280263_116280484 | 0.62 |
RGS3 |
regulator of G-protein signaling 3 |
823 |
0.68 |
chr5_130405277_130405629 | 0.62 |
HINT1 |
histidine triad nucleotide binding protein 1 |
92867 |
0.09 |
chr1_100823290_100823730 | 0.62 |
CDC14A |
cell division cycle 14A |
5005 |
0.21 |
chr1_205575143_205575294 | 0.61 |
ENSG00000206762 |
. |
11049 |
0.15 |
chr2_162807979_162808245 | 0.61 |
ENSG00000253046 |
. |
32820 |
0.21 |
chr5_96139289_96139440 | 0.61 |
CTD-2260A17.3 |
|
692 |
0.61 |
chr12_14588679_14588830 | 0.61 |
ATF7IP |
activating transcription factor 7 interacting protein |
12059 |
0.23 |
chr11_47936391_47936542 | 0.60 |
PTPRJ |
protein tyrosine phosphatase, receptor type, J |
65647 |
0.09 |
chr14_68749508_68749848 | 0.60 |
ENSG00000243546 |
. |
46422 |
0.17 |
chr5_158603640_158603791 | 0.60 |
RNF145 |
ring finger protein 145 |
30927 |
0.15 |
chr17_38768487_38768663 | 0.60 |
SMARCE1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 |
19967 |
0.13 |
chr2_198131017_198131373 | 0.59 |
ANKRD44-IT1 |
ANKRD44 intronic transcript 1 (non-protein coding) |
36048 |
0.14 |
chr4_15768202_15768353 | 0.59 |
CD38 |
CD38 molecule |
11624 |
0.22 |
chr1_212399114_212399334 | 0.59 |
PPP2R5A |
protein phosphatase 2, regulatory subunit B', alpha |
59655 |
0.1 |
chr8_66715380_66715659 | 0.59 |
PDE7A |
phosphodiesterase 7A |
14200 |
0.26 |
chr14_68760088_68760299 | 0.59 |
ENSG00000243546 |
. |
56937 |
0.15 |
chrX_19854268_19854593 | 0.59 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
36561 |
0.2 |
chr10_107599753_107599904 | 0.58 |
ENSG00000207068 |
. |
305411 |
0.01 |
chr3_187678021_187678172 | 0.58 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
192976 |
0.03 |
chrX_106230754_106231110 | 0.58 |
MORC4 |
MORC family CW-type zinc finger 4 |
5638 |
0.26 |
chr8_101231809_101232060 | 0.58 |
ENSG00000199667 |
. |
34568 |
0.13 |
chr1_200709003_200709249 | 0.58 |
CAMSAP2 |
calmodulin regulated spectrin-associated protein family, member 2 |
219 |
0.96 |
chr1_100908166_100908711 | 0.58 |
RP5-837M10.4 |
|
43115 |
0.14 |
chr5_94959224_94959533 | 0.58 |
GPR150 |
G protein-coupled receptor 150 |
3596 |
0.22 |
chr8_126937549_126937701 | 0.58 |
ENSG00000206695 |
. |
24430 |
0.28 |
chr17_47811103_47811254 | 0.58 |
FAM117A |
family with sequence similarity 117, member A |
9289 |
0.15 |
chr11_118177987_118178215 | 0.57 |
CD3E |
CD3e molecule, epsilon (CD3-TCR complex) |
2487 |
0.19 |
chr4_108971239_108971469 | 0.57 |
HADH |
hydroxyacyl-CoA dehydrogenase |
45563 |
0.15 |
chr1_100917512_100917831 | 0.57 |
RP5-837M10.4 |
|
33882 |
0.17 |
chr5_14598149_14598547 | 0.57 |
FAM105A |
family with sequence similarity 105, member A |
16464 |
0.23 |
chr6_139601830_139602039 | 0.56 |
RP11-445F6.2 |
|
2310 |
0.31 |
chr15_93434922_93435306 | 0.56 |
CHD2 |
chromodomain helicase DNA binding protein 2 |
7944 |
0.19 |
chr3_16981270_16981749 | 0.56 |
ENSG00000264818 |
. |
6821 |
0.24 |
chr5_180609174_180609509 | 0.56 |
CTC-338M12.5 |
|
9583 |
0.09 |
chr12_46632171_46632463 | 0.56 |
SLC38A1 |
solute carrier family 38, member 1 |
29167 |
0.24 |
chr2_232327933_232328303 | 0.56 |
NCL |
nucleolin |
286 |
0.82 |
chr20_50116677_50116828 | 0.56 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
42506 |
0.17 |
chr5_77015099_77015250 | 0.56 |
TBCA |
tubulin folding cofactor A |
4032 |
0.32 |
chr14_96592527_96592755 | 0.56 |
ENSG00000221236 |
. |
10547 |
0.18 |
chr10_27634072_27634223 | 0.55 |
ENSG00000207135 |
. |
9611 |
0.19 |
chr1_206956376_206956527 | 0.55 |
IL10 |
interleukin 10 |
10612 |
0.16 |
chr10_6641390_6641541 | 0.55 |
PRKCQ |
protein kinase C, theta |
19202 |
0.29 |
chr9_98742828_98743012 | 0.55 |
ERCC6L2 |
excision repair cross-complementing rodent repair deficiency, complementation group 6-like 2 |
7801 |
0.27 |
chr1_211780615_211780961 | 0.55 |
RP11-359E8.5 |
|
23721 |
0.15 |
chr2_69866079_69866236 | 0.55 |
AAK1 |
AP2 associated kinase 1 |
4629 |
0.24 |
chr4_48203549_48203887 | 0.55 |
ENSG00000202014 |
. |
48267 |
0.12 |
chr8_80966732_80966883 | 0.55 |
MRPS28 |
mitochondrial ribosomal protein S28 |
24283 |
0.18 |
chr20_1344193_1344436 | 0.55 |
RP11-314N13.3 |
|
2048 |
0.25 |
chr9_110053568_110053785 | 0.55 |
RAD23B |
RAD23 homolog B (S. cerevisiae) |
6700 |
0.31 |
chr1_41160471_41160622 | 0.55 |
NFYC |
nuclear transcription factor Y, gamma |
2584 |
0.21 |
chr11_36434278_36434429 | 0.55 |
PRR5L |
proline rich 5 like |
11738 |
0.18 |
chr3_15843084_15843262 | 0.55 |
ANKRD28 |
ankyrin repeat domain 28 |
5145 |
0.24 |
chr22_20819732_20820026 | 0.55 |
ENSG00000255156 |
. |
9719 |
0.1 |
chr2_172959606_172960051 | 0.54 |
DLX2 |
distal-less homeobox 2 |
7800 |
0.21 |
chr12_68024949_68025235 | 0.54 |
DYRK2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
17026 |
0.25 |
chr12_116647785_116648171 | 0.54 |
RP11-115H15.2 |
|
28878 |
0.17 |
chr7_139554493_139554816 | 0.54 |
TBXAS1 |
thromboxane A synthase 1 (platelet) |
25544 |
0.23 |
chr22_45570848_45571064 | 0.54 |
CTA-268H5.12 |
|
3915 |
0.19 |
chr6_71360263_71360634 | 0.53 |
SMAP1 |
small ArfGAP 1 |
17031 |
0.26 |
chr10_120855557_120855892 | 0.53 |
FAM45A |
family with sequence similarity 45, member A |
7876 |
0.14 |
chr10_8449222_8449415 | 0.53 |
ENSG00000212505 |
. |
249476 |
0.02 |
chr2_68606734_68606885 | 0.53 |
AC015969.3 |
|
14093 |
0.17 |
chr14_91501757_91501911 | 0.53 |
RPS6KA5 |
ribosomal protein S6 kinase, 90kDa, polypeptide 5 |
24644 |
0.17 |
chr19_19176974_19177125 | 0.53 |
SLC25A42 |
solute carrier family 25, member 42 |
2241 |
0.21 |
chr2_44901800_44902050 | 0.53 |
ENSG00000252896 |
. |
107344 |
0.07 |
chr1_203291434_203291646 | 0.53 |
ENSG00000202300 |
. |
3313 |
0.22 |
chrX_78406329_78406539 | 0.53 |
GPR174 |
G protein-coupled receptor 174 |
20035 |
0.29 |
chr11_3918269_3918516 | 0.53 |
STIM1 |
stromal interaction molecule 1 |
6301 |
0.14 |
chr11_118087590_118088000 | 0.53 |
AMICA1 |
adhesion molecule, interacts with CXADR antigen 1 |
2189 |
0.24 |
chr5_156641801_156641952 | 0.53 |
CTB-4E7.1 |
|
9514 |
0.13 |
chr8_142114570_142114965 | 0.53 |
DENND3 |
DENN/MADD domain containing 3 |
12610 |
0.2 |
chr4_38456816_38456967 | 0.52 |
RP11-617D20.1 |
|
169305 |
0.03 |
chr11_36438099_36438541 | 0.52 |
RP11-219O3.2 |
|
9352 |
0.19 |
chr13_41532996_41533147 | 0.52 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
23347 |
0.16 |
chr9_79345873_79346024 | 0.52 |
PRUNE2 |
prune homolog 2 (Drosophila) |
20795 |
0.21 |
chr1_112014892_112015096 | 0.52 |
C1orf162 |
chromosome 1 open reading frame 162 |
1420 |
0.25 |
chr11_73723870_73724108 | 0.52 |
UCP3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
3509 |
0.2 |
chr12_50796054_50796251 | 0.52 |
LARP4 |
La ribonucleoprotein domain family, member 4 |
1176 |
0.48 |
chr10_64451243_64451462 | 0.52 |
ENSG00000263920 |
. |
33407 |
0.18 |
chr4_103448528_103448679 | 0.51 |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
24071 |
0.18 |
chr6_26406613_26406840 | 0.51 |
BTN3A1 |
butyrophilin, subfamily 3, member A1 |
4203 |
0.12 |
chr3_43341661_43341812 | 0.51 |
SNRK |
SNF related kinase |
13658 |
0.17 |
chr9_107910216_107910462 | 0.51 |
ENSG00000201583 |
. |
51302 |
0.16 |
chrX_40499635_40499786 | 0.51 |
CXorf38 |
chromosome X open reading frame 38 |
7063 |
0.22 |
chr7_155449708_155449859 | 0.51 |
RBM33 |
RNA binding motif protein 33 |
12387 |
0.21 |
chrX_8955459_8955610 | 0.51 |
FAM9B |
family with sequence similarity 9, member B |
45582 |
0.2 |
chr2_191929273_191929916 | 0.51 |
ENSG00000231858 |
. |
43342 |
0.12 |
chr15_63825751_63825933 | 0.50 |
USP3 |
ubiquitin specific peptidase 3 |
1137 |
0.54 |
chr13_25200724_25201013 | 0.50 |
ENSG00000211508 |
. |
17651 |
0.18 |
chr4_13617345_13617663 | 0.50 |
BOD1L1 |
biorientation of chromosomes in cell division 1-like 1 |
11843 |
0.2 |
chr1_81678243_81678394 | 0.50 |
ENSG00000223026 |
. |
39156 |
0.21 |
chrX_153323115_153323266 | 0.50 |
ENSG00000211524 |
. |
37750 |
0.09 |
chrX_123219671_123219822 | 0.50 |
ENSG00000239058 |
. |
47388 |
0.17 |
chr1_1109574_1109820 | 0.50 |
TTLL10 |
tubulin tyrosine ligase-like family, member 10 |
411 |
0.66 |
chr2_175446825_175447268 | 0.50 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
3271 |
0.21 |
chr19_54879768_54880096 | 0.50 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
2126 |
0.19 |
chr9_37085723_37085874 | 0.49 |
RP11-220I1.2 |
|
29689 |
0.15 |
chr3_52298408_52298580 | 0.49 |
ENSG00000199150 |
. |
3885 |
0.1 |
chr9_77767662_77767852 | 0.49 |
ENSG00000200041 |
. |
28780 |
0.16 |
chr11_128175433_128175800 | 0.49 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
199673 |
0.03 |
chrX_154116005_154116287 | 0.49 |
ENSG00000221533 |
. |
413 |
0.67 |
chr21_32506457_32506683 | 0.49 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
4031 |
0.33 |
chr11_95420301_95420529 | 0.49 |
FAM76B |
family with sequence similarity 76, member B |
99554 |
0.08 |
chrX_154686345_154686835 | 0.49 |
ENSG00000221603 |
. |
588 |
0.57 |
chr13_74672570_74672721 | 0.49 |
KLF12 |
Kruppel-like factor 12 |
35749 |
0.24 |
chr6_6593122_6593282 | 0.48 |
LY86 |
lymphocyte antigen 86 |
4300 |
0.27 |
chr13_100012790_100013013 | 0.48 |
ENSG00000207719 |
. |
4516 |
0.25 |
chr2_68385602_68386003 | 0.48 |
PNO1 |
partner of NOB1 homolog (S. cerevisiae) |
826 |
0.45 |
chr9_92141364_92141857 | 0.48 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
28565 |
0.19 |
chr6_157421825_157422002 | 0.48 |
RP1-137K2.2 |
|
18927 |
0.25 |
chr1_169664801_169665268 | 0.48 |
SELL |
selectin L |
15805 |
0.19 |
chr12_68025335_68025706 | 0.48 |
DYRK2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
16598 |
0.25 |
chr17_1100600_1101315 | 0.47 |
ABR |
active BCR-related |
10341 |
0.19 |
chr17_262742_262893 | 0.47 |
AC108004.3 |
|
997 |
0.44 |
chr2_25516869_25517568 | 0.47 |
ENSG00000221445 |
. |
34372 |
0.16 |
chr15_92470898_92471049 | 0.47 |
SLCO3A1 |
solute carrier organic anion transporter family, member 3A1 |
73622 |
0.12 |
chr1_169660668_169660923 | 0.47 |
SELL |
selectin L |
20044 |
0.18 |
chr7_138783506_138783787 | 0.47 |
ZC3HAV1 |
zinc finger CCCH-type, antiviral 1 |
10454 |
0.21 |
chr1_110094975_110095126 | 0.47 |
GNAI3 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
3817 |
0.12 |
chr6_159530690_159531010 | 0.47 |
RP11-13P5.2 |
|
57535 |
0.11 |
chr11_118085464_118085638 | 0.47 |
AMICA1 |
adhesion molecule, interacts with CXADR antigen 1 |
55 |
0.97 |
chr6_20181272_20181565 | 0.47 |
RP11-239H6.2 |
|
30900 |
0.19 |
chr2_46577756_46578032 | 0.47 |
EPAS1 |
endothelial PAS domain protein 1 |
53353 |
0.14 |
chr4_36242269_36242420 | 0.46 |
ARAP2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
3217 |
0.26 |
chr10_6101868_6102200 | 0.46 |
IL2RA |
interleukin 2 receptor, alpha |
2219 |
0.25 |
chr12_15106372_15106523 | 0.46 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
2362 |
0.25 |
chr9_88953538_88953925 | 0.46 |
ZCCHC6 |
zinc finger, CCHC domain containing 6 |
4307 |
0.27 |
chr15_60267965_60268474 | 0.46 |
FOXB1 |
forkhead box B1 |
28202 |
0.25 |
chr3_15562513_15562908 | 0.45 |
COLQ |
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
533 |
0.72 |
chr11_6758586_6758829 | 0.45 |
GVINP1 |
GTPase, very large interferon inducible pseudogene 1 |
15596 |
0.12 |
chr14_60719501_60719652 | 0.45 |
PPM1A |
protein phosphatase, Mg2+/Mn2+ dependent, 1A |
2427 |
0.3 |
chr12_795549_795778 | 0.45 |
NINJ2 |
ninjurin 2 |
22718 |
0.17 |
chr1_160595319_160595764 | 0.45 |
SLAMF1 |
signaling lymphocytic activation molecule family member 1 |
21270 |
0.14 |
chr7_127427986_127428137 | 0.45 |
SND1 |
staphylococcal nuclease and tudor domain containing 1 |
99904 |
0.07 |
chr5_67534562_67534771 | 0.45 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
1060 |
0.63 |
chr5_112859873_112860055 | 0.45 |
YTHDC2 |
YTH domain containing 2 |
10121 |
0.2 |
chr20_50036283_50036434 | 0.45 |
ENSG00000266761 |
. |
33156 |
0.19 |
chr1_20016120_20016277 | 0.45 |
HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
24418 |
0.16 |
chr15_60852222_60852373 | 0.45 |
CTD-2501E16.2 |
|
30125 |
0.16 |
chr3_107798287_107798438 | 0.45 |
CD47 |
CD47 molecule |
11499 |
0.3 |
chr7_158616385_158616577 | 0.45 |
ESYT2 |
extended synaptotagmin-like protein 2 |
5682 |
0.26 |
chr7_36337294_36337445 | 0.45 |
EEPD1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
616 |
0.72 |
chr16_27458426_27458577 | 0.45 |
IL21R-AS1 |
IL21R antisense RNA 1 |
6213 |
0.2 |
chr1_160535323_160535488 | 0.45 |
CD84 |
CD84 molecule |
13858 |
0.13 |
chr5_101009129_101009280 | 0.45 |
ENSG00000264318 |
. |
91670 |
0.1 |
chr20_47369313_47369511 | 0.44 |
ENSG00000251876 |
. |
13427 |
0.27 |
chr2_48375694_48375845 | 0.44 |
ENSG00000201010 |
. |
68945 |
0.13 |
chr5_52072365_52072556 | 0.44 |
ITGA1 |
integrin, alpha 1 |
11270 |
0.19 |
chrX_128916830_128917250 | 0.44 |
SASH3 |
SAM and SH3 domain containing 3 |
3080 |
0.26 |
chr5_169074930_169075085 | 0.44 |
DOCK2 |
dedicator of cytokinesis 2 |
10756 |
0.25 |
chr16_31881802_31882312 | 0.44 |
ZNF267 |
zinc finger protein 267 |
3022 |
0.3 |
chr11_114042469_114043098 | 0.44 |
ENSG00000221112 |
. |
85132 |
0.08 |
chr2_101268394_101268545 | 0.44 |
ENSG00000265839 |
. |
51141 |
0.13 |
chr17_4404014_4404514 | 0.44 |
AC118754.4 |
|
1295 |
0.31 |
chr10_74919029_74919180 | 0.44 |
ECD |
ecdysoneless homolog (Drosophila) |
8713 |
0.11 |
chr3_43340391_43340566 | 0.44 |
SNRK |
SNF related kinase |
12400 |
0.17 |
chr13_100511640_100511791 | 0.44 |
CLYBL |
citrate lyase beta like |
600 |
0.78 |
chr2_109227457_109227608 | 0.44 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
3915 |
0.29 |
chr2_136964454_136964798 | 0.44 |
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
88891 |
0.09 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 0.7 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.2 | 0.6 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.9 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.1 | 0.2 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.3 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.4 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.3 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.3 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.1 | 1.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.2 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.2 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.1 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.2 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.3 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.3 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.3 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.2 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.1 | 0.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.2 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.1 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.3 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.1 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
0.1 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.3 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.2 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.0 | 0.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.2 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.1 | GO:0003181 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.0 | 0.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.0 | 0.5 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.2 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.0 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.0 | 0.1 | GO:1904063 | negative regulation of calcium ion import(GO:0090281) negative regulation of cation transmembrane transport(GO:1904063) |
0.0 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.3 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.2 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.4 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.3 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.0 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.1 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.0 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.2 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.0 | 0.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.1 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.0 | 0.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.1 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.3 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.1 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.0 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.0 | 0.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.1 | GO:2000351 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.0 | 0.2 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.0 | GO:0002839 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.0 | 0.4 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.1 | GO:0043368 | positive T cell selection(GO:0043368) |
0.0 | 0.1 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.0 | 0.0 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.0 | 0.1 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.3 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.2 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.0 | 0.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.3 | GO:0051806 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.0 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:1903038 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.0 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.2 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.1 | GO:0031579 | membrane raft organization(GO:0031579) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.0 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.0 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.0 | 0.4 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.0 | GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.0 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.0 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.0 | GO:0071637 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.0 | 0.2 | GO:0050718 | positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.1 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.1 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 0.0 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.0 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.2 | GO:0000303 | response to superoxide(GO:0000303) |
0.0 | 0.0 | GO:0072179 | nephric duct formation(GO:0072179) |
0.0 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.0 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.0 | 0.8 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:0090192 | regulation of glomerulus development(GO:0090192) |
0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.0 | GO:0060197 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.0 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.0 | 0.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.1 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.1 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.0 | 0.0 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.0 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.0 | 0.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.0 | GO:0043301 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.0 | 0.1 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.0 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.0 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.2 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.0 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.0 | 0.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.0 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.1 | GO:1901998 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 | 0.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.0 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.1 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.0 | GO:0021778 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.0 | 0.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0038061 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.6 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.1 | GO:0033363 | secretory granule organization(GO:0033363) |
0.0 | 0.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.0 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.1 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.2 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.1 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.0 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.6 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 0.0 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.0 | 0.1 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.0 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.0 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.2 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 0.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.0 | GO:0032747 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.0 | GO:0031054 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) pre-miRNA processing(GO:0031054) |
0.0 | 0.0 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.0 | 0.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.0 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.4 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.0 | 0.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.0 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.0 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.0 | 0.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.0 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.0 | 0.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.1 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.1 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.2 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.0 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.0 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.0 | 0.0 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.0 | 0.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.0 | GO:0051026 | chiasma assembly(GO:0051026) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.1 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.3 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.1 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.5 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.2 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.3 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 1.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.4 | GO:0009295 | nucleoid(GO:0009295) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.0 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.0 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.0 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 0.0 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 1.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.7 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.5 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.2 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.0 | 0.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.0 | 0.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.1 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 1.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.8 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.0 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.3 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 0.1 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0046970 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.0 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.1 | GO:0090079 | translation activator activity(GO:0008494) translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.0 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.0 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.3 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.0 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.0 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.2 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.4 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 1.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 1.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 0.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 1.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 1.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.7 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.2 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |